MX2021000583A - Producto de grafeno y usos terapeuticos del mismo. - Google Patents
Producto de grafeno y usos terapeuticos del mismo.Info
- Publication number
- MX2021000583A MX2021000583A MX2021000583A MX2021000583A MX2021000583A MX 2021000583 A MX2021000583 A MX 2021000583A MX 2021000583 A MX2021000583 A MX 2021000583A MX 2021000583 A MX2021000583 A MX 2021000583A MX 2021000583 A MX2021000583 A MX 2021000583A
- Authority
- MX
- Mexico
- Prior art keywords
- product
- therapeutic uses
- graphene
- graphene product
- gnfs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B32/00—Carbon; Compounds thereof
- C01B32/15—Nano-sized carbon materials
- C01B32/182—Graphene
- C01B32/184—Preparation
- C01B32/19—Preparation by exfoliation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B32/00—Carbon; Compounds thereof
- C01B32/15—Nano-sized carbon materials
- C01B32/18—Nanoonions; Nanoscrolls; Nanohorns; Nanocones; Nanowalls
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B32/00—Carbon; Compounds thereof
- C01B32/15—Nano-sized carbon materials
- C01B32/182—Graphene
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B32/00—Carbon; Compounds thereof
- C01B32/15—Nano-sized carbon materials
- C01B32/182—Graphene
- C01B32/198—Graphene oxide
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B2204/00—Structure or properties of graphene
- C01B2204/20—Graphene characterized by its properties
- C01B2204/30—Purity
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B2204/00—Structure or properties of graphene
- C01B2204/20—Graphene characterized by its properties
- C01B2204/32—Size or surface area
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/01—Crystal-structural characteristics depicted by a TEM-image
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/74—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by peak-intensities or a ratio thereof only
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
- C01P2002/82—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by IR- or Raman-data
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/03—Particle morphology depicted by an image obtained by SEM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/04—Particle morphology depicted by an image obtained by TEM, STEM, STM or AFM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/51—Particles with a specific particle size distribution
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/12—Surface area
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/14—Pore volume
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/16—Pore diameter
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/40—Electric properties
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/80—Compositional purity
Abstract
Se describe un producto de grafeno obtenido a partir de Nanofibras de Grafeno (GNFs), que tienen una estructura cristalina modificada y una distribución de tamaño definida. El producto tiene propiedades biológicas no tóxicas y útiles tales como la cicatrización de heridas y el mejoramiento del aspecto de la piel. El producto se puede usar en terapia.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18382531.4A EP3597594A1 (en) | 2018-07-17 | 2018-07-17 | Graphene product and therapeutic uses thereof |
PCT/EP2019/069288 WO2020016324A1 (en) | 2018-07-17 | 2019-07-17 | Graphene product and therapeutic uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021000583A true MX2021000583A (es) | 2021-06-23 |
Family
ID=62986031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021000583A MX2021000583A (es) | 2018-07-17 | 2019-07-17 | Producto de grafeno y usos terapeuticos del mismo. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20210292171A1 (es) |
EP (2) | EP3597594A1 (es) |
JP (1) | JP7381113B2 (es) |
KR (1) | KR20210031495A (es) |
CN (1) | CN112469664B (es) |
AU (1) | AU2019304509A1 (es) |
BR (1) | BR112021000641A2 (es) |
CA (1) | CA3104638A1 (es) |
ES (1) | ES2964222T3 (es) |
IL (1) | IL280150A (es) |
MX (1) | MX2021000583A (es) |
RU (1) | RU2765294C1 (es) |
SG (1) | SG11202013207XA (es) |
WO (1) | WO2020016324A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3597595A1 (en) * | 2018-07-17 | 2020-01-22 | Graphenano Medical Care, S.L. | Graphene product and cosmetic uses thereof |
CN112057747B (zh) * | 2020-08-17 | 2021-05-07 | 菏泽鑫盛达新材料有限公司 | 一种用于热敷材料的石墨烯材料及其制备方法 |
EP4079284A1 (en) | 2021-04-23 | 2022-10-26 | Graphenano Medical Care, S.L. | A graphene nanomaterial for use as a fat adborbent |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU605920B2 (en) | 1987-10-21 | 1991-01-24 | Atochem North America, Inc. | Morpholinyl silanes and use for control of plant diseases caused by fungi |
US20060134096A1 (en) | 2004-12-22 | 2006-06-22 | Supracarbonic, Llc | Compositions and methods for medical use of graphene-containing compositions |
EP2392700B1 (en) * | 2010-04-28 | 2012-06-20 | Teijin Aramid B.V. | Process for spinning graphene ribbon fibers |
CN102690648B (zh) * | 2011-03-22 | 2016-05-18 | 北京师范大学 | 石墨烯荧光纳米材料、其制备及应用 |
WO2013066398A1 (en) | 2011-04-26 | 2013-05-10 | William Marsh Rice University | Use of carbon nanomaterials with antioxidant properties to treat oxidative stress |
CN103796766B (zh) * | 2011-09-14 | 2017-05-31 | 威廉马歇莱思大学 | 用于制备石墨烯纳米带的基于溶剂的方法 |
JP2013133257A (ja) | 2011-12-26 | 2013-07-08 | Toshiba Corp | ナノグラフェンの製造方法及びその製造装置 |
CA2923035A1 (en) | 2013-09-03 | 2015-03-12 | William Marsh Rice University | Treatment of inflammatory diseases by carbon materials |
CN103482620B (zh) * | 2013-09-11 | 2016-01-20 | 黄镇东 | 氧化或还原石墨烯基网格材料及其制备方法 |
GB2532449A (en) | 2014-11-19 | 2016-05-25 | Univ Manchester | Use of Nanomaterials in treating cancer |
JP2016158680A (ja) * | 2015-02-27 | 2016-09-05 | 国立大学法人北海道大学 | 酸化グラフェンを用いた骨再生用又は皮膚再生用スキャフォールド |
CN106521719A (zh) * | 2016-11-10 | 2017-03-22 | 过冬 | 一种石墨烯基碳纳米纤维的制备方法 |
CN107137753B (zh) * | 2017-05-09 | 2020-03-31 | 重庆大学 | 一种石墨烯/碳纳米纤维生物医用外敷无纺布的制备方法 |
EP3597595A1 (en) * | 2018-07-17 | 2020-01-22 | Graphenano Medical Care, S.L. | Graphene product and cosmetic uses thereof |
-
2018
- 2018-07-17 EP EP18382531.4A patent/EP3597594A1/en not_active Withdrawn
-
2019
- 2019-07-17 SG SG11202013207XA patent/SG11202013207XA/en unknown
- 2019-07-17 US US17/258,815 patent/US20210292171A1/en active Pending
- 2019-07-17 MX MX2021000583A patent/MX2021000583A/es unknown
- 2019-07-17 CN CN201980047676.7A patent/CN112469664B/zh active Active
- 2019-07-17 WO PCT/EP2019/069288 patent/WO2020016324A1/en active Application Filing
- 2019-07-17 EP EP19742032.6A patent/EP3823928B1/en active Active
- 2019-07-17 BR BR112021000641-9A patent/BR112021000641A2/pt unknown
- 2019-07-17 ES ES19742032T patent/ES2964222T3/es active Active
- 2019-07-17 AU AU2019304509A patent/AU2019304509A1/en active Pending
- 2019-07-17 CA CA3104638A patent/CA3104638A1/en active Pending
- 2019-07-17 JP JP2021503057A patent/JP7381113B2/ja active Active
- 2019-07-17 RU RU2020143164A patent/RU2765294C1/ru active
- 2019-07-17 KR KR1020217004341A patent/KR20210031495A/ko active Search and Examination
-
2021
- 2021-01-13 IL IL280150A patent/IL280150A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2019304509A1 (en) | 2021-01-28 |
EP3823928B1 (en) | 2023-10-11 |
EP3597594A1 (en) | 2020-01-22 |
CN112469664A (zh) | 2021-03-09 |
CN112469664B (zh) | 2023-07-14 |
JP7381113B2 (ja) | 2023-11-15 |
CA3104638A1 (en) | 2020-01-23 |
JP2021532045A (ja) | 2021-11-25 |
EP3823928A1 (en) | 2021-05-26 |
IL280150A (en) | 2021-03-01 |
BR112021000641A2 (pt) | 2021-04-06 |
EP3823928C0 (en) | 2023-10-11 |
ES2964222T3 (es) | 2024-04-04 |
SG11202013207XA (en) | 2021-01-28 |
KR20210031495A (ko) | 2021-03-19 |
WO2020016324A1 (en) | 2020-01-23 |
RU2765294C1 (ru) | 2022-01-28 |
US20210292171A1 (en) | 2021-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000583A (es) | Producto de grafeno y usos terapeuticos del mismo. | |
MX353955B (es) | Hebras de acido hialuronico reticulado y metodos de uso de las mismas. | |
WO2012143497A3 (de) | Neue binder-wirkstoff konjugate (adcs) und ihre verwendung | |
MX2021000584A (es) | Producto grafeno y sus usos cosmeticos. | |
WO2019040106A3 (en) | COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES | |
NZ582556A (en) | Pharmaceutical composition for treating wounds and related methods | |
ZA201805358B (en) | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | |
AU2022259716B2 (en) | Treatment of pain with polysulfated polysaccharides | |
NZ729181A (en) | Treatment of disease with poly-n-acetylglucosamine nanofibers | |
MX2018004015A (es) | Metodos y articulos de fabricacion para el tratamiento de animales. | |
EP3937980A4 (en) | MODIFIED MIARNS AND THEIR USE IN THE TREATMENT OF CANCER | |
MX2021004207A (es) | Uso de reboxetina para el tratamiento de narcolepsia. | |
PH12021551235A1 (en) | Elacestrant in combination with abemaciclib in women with breast cancer | |
MX2017009325A (es) | Gel intestinal de levodopa y carbidopa y metodos de uso. | |
AU2017394032A8 (en) | Use of paeoniflorin-6'-o-benzenesulfonate in treatment of sjögren's syndrome | |
ZA202306279B (en) | Therapy of post-operative emesis with amisulpride | |
WO2019040105A3 (en) | COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES | |
SG11201909144VA (en) | Bacterial secretome for use in the treatment of skin lesions | |
WO2019099860A3 (en) | Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing | |
PH12014501044A1 (en) | Methods for improved wound closure employing olivamine and human umbilical vien endothelial cells | |
CN203763324U (zh) | 骨折固定装置 | |
MX2017017192A (es) | Biopolimero de quitosano y poloxamero 407 obtenido por irradiacion gamma que exhibe propiedades fisicoqumicas y biologicas para la reparacion de heridas. | |
NZ631362A (en) | Arry-520 for use in treating cancer in a patient with low aag | |
TR201903241A2 (tr) | Metali̇k nano gümüş i̇çeri̇kli̇ poli̇üretan sünger | |
MD757Z (ro) | Metodă de tratament al arsurilor de gradul I...IIIB |